
Home » PROMETIC CLOSES C$10.8 MILLION PRIVATE PLACEMENT
PROMETIC CLOSES C$10.8 MILLION PRIVATE PLACEMENT
ProMetic Life Sciences Inc. announced today that it closed a previously announced private placement of 29,600,000 subordinate voting shares at C$0.365 per share with JPMorgan and Third Point LLC. Proceeds from the private placement totaled C$10.8 million.
Market Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb
-
07Mar